Combination therapy (ribavirin and interferon alpha) to replace interferon alfa alone for the treatment of patients with moderate hepatitis C.
Wessex Institute for Health Research and Development.Development & Evaluation Committee.
[Southampton] : Wessex Institute for Health Research & Development,
1999.